Concepedia

Hsu-Ping Kuo

HK

Statistics

Publications

7

Citations

538

H-Index

7

Active since

2005

Affiliations

AbbVie (United States)(Current)

Pharmacyclics (United States)

Hsu-Ping Kuo is an author at AbbVie (United States) specializing in medicine, cell biology, and radiation oncology.

Top concepts

Publications per year

2005–2021

7

Publications

7

Combination of Conformal Radiotherapy and Intratumoral Injection of Adoptive Dendritic Cell Immunotherapy in Refractory Hepatoma

Kwan‐Hwa Chi, Shih‐Jen Liu, Chung‐Pin Li et al. · Journal of Immunotherapy · 2005 · 184 citations

, , +21

The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential

Stephen H.K. Wong, David L. Goode, Masayuki Iwasaki et al. · Cancer Cell · 2015 · 138 citations

, , +4

The Role of PIM1 in the Ibrutinib-Resistant ABC Subtype of Diffuse Large B-Cell Lymphoma

Hsu-Ping Kuo, Sidney Hsieh, Karl J. Schweighofer et al. · Blood · 2015 · 64 citations

Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Hsu-Ping Kuo, Scott A. Ezell, Karl J. Schweighofer et al. · Molecular Cancer Therapeutics · 2017 · 63 citations · Full text

The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.

Hsu-Ping Kuo, Scott A. Ezell, Sidney Hsieh et al. · PubMed · 2016 · 55 citations · Full text

1–5 of 7